Stakeholders seek clarity on FDA cell and gene therapy draft guidance | RAPS

Instead of an iterative approach to clinical studies, multiple versions of a cellular or gene therapy product can be studied in parallel, ...
https://www.google.com/url?rct=j&sa=t&url=https://www.raps.org/news-and-articles/news-articles/2022/1/stakeholders-seek-clarity-on-fda-cell-and-gene-the&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHEOfwS0alB69jTijznE8W-Kp4DWQ